Paper25614448
Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.
Küçük C and 10 others. Clin Cancer Res, 2015. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Papers, record 25614448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25614448
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Methylation | Major topic |
| Genes, Tumor Suppressor | Major topic |
| Lymphoma, Extranodal NK-T-Cell | Major topic |
| Humans | |
| Promoter Regions, Genetic | |
| Transcriptome |
Source PubMed
Grants14
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 CA114778 | NCI NIH HHS | United States | U01CA114778 | PubMed and NIH | NIH RePORTER |
| P20 GM103427 | NIGMS NIH HHS | United States | P20GM103427 | PubMed and NIH | NIH RePORTER |
| P30 GM110768 | NIGMS NIH HHS | United States | P30GM110768 | PubMed and NIH | NIH RePORTER |
| RR018788-08 | NCRR NIH HHS | United States | PubMed | PubMed | |
| 1S10RR027754-01 | NCRR NIH HHS | United States | S10RR027754 | PubMed and NIH | NIH RePORTER |
| 8P20GM103427 | NIGMS NIH HHS | United States | P20GM103427 | PubMed and NIH | NIH RePORTER |
| P20 GM103471 | NIGMS NIH HHS | United States | P20GM103471 | PubMed and NIH | NIH RePORTER |
| S10 RR027754 | NCRR NIH HHS | United States | S10RR027754 | PubMed and NIH | NIH RePORTER |
| P20 RR016469 | NCRR NIH HHS | United States | P20RR016469 | PubMed and NIH | NIH RePORTER |
| P20 RR018788 | NCRR NIH HHS | United States | P20RR018788 | PubMed and NIH | NIH RePORTER |
| P30 CA033572 | NCI NIH HHS | United States | P30CA033572 | PubMed and NIH | NIH RePORTER |
| 5P20RR016469 | NCRR NIH HHS | United States | P20RR016469 | PubMed and NIH | NIH RePORTER |
| P50 CA136411 | NCI NIH HHS | United States | P50CA136411 | PubMed and NIH | NIH RePORTER |
| GM103471-09 | NIGMS NIH HHS | United States | PubMed | PubMed |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22133874 | Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22133874 | PubMed |
| 2 | 24744378 | The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. | Science | 2014 | https://conductscience.org/library/papers/24744378 | PubMed |
| 3 | 22391556 | A DNA hypermethylation module for the stem/progenitor cell signature of cancer. | Genome Res | 2012 | https://conductscience.org/library/papers/22391556 | PubMed |
| 4 | 22584624 | BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22584624 | PubMed |
| 5 | 23144151 | Suppression of Zinc Finger Homeobox 3 expression in tumor cells decreases the survival rate among non-small cell lung cancer patients. | Cancer Biomark | 2012 | https://conductscience.org/library/papers/23144151 | PubMed |
| 6 | 23653113 | MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. | Pathol Oncol Res | 2013 | https://conductscience.org/library/papers/23653113 | PubMed |
| 7 | 23281437 | Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. | Mod Pathol | 2013 | https://conductscience.org/library/papers/23281437 | PubMed |
| 8 | 12042769 | The fundamental role of epigenetic events in cancer. | Nat Rev Genet | 2002 | https://conductscience.org/library/papers/12042769 | PubMed |
| 9 | 12438221 | Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. | Cancer Res | 2002 | https://conductscience.org/library/papers/12438221 | PubMed |
| 10 | 14715251 | ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/14715251 | PubMed |
| 11 | 14614518 | SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. | Leukemia | 2004 | https://conductscience.org/library/papers/14614518 | PubMed |
| 12 | 4898857 | L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. | N Engl J Med | 1969 | https://conductscience.org/library/papers/4898857 | PubMed |
| 13 | 7568001 | Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7568001 | PubMed |
| 14 | 15608685 | dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. | Oncogene | 2005 | https://conductscience.org/library/papers/15608685 | PubMed |
| 15 | 15718422 | Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. | Blood | 2005 | https://conductscience.org/library/papers/15718422 | PubMed |
| 16 | 16081683 | Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. | Blood | 2005 | https://conductscience.org/library/papers/16081683 | PubMed |
| 17 | 17072317 | DNA methylation profiling of human chromosomes 6, 20 and 22. | Nat Genet | 2006 | https://conductscience.org/library/papers/17072317 | PubMed |
| 18 | 17211412 | A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. | Nat Genet | 2007 | https://conductscience.org/library/papers/17211412 | PubMed |
| 19 | 17540169 | Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. | Cell | 2007 | https://conductscience.org/library/papers/17540169 | PubMed |
| 20 | 17603019 | The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels. | Biochem Biophys Res Commun | 2007 | https://conductscience.org/library/papers/17603019 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42557242 | Identification of methylation-sensitive human transcription factors using meSMiLE-seq. | Nat Commun | 2026 | https://conductscience.org/library/papers/42557242 | PubMed |
| 42457877 | DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups. | Leukemia | 2026 | https://conductscience.org/library/papers/42457877 | PubMed |
| 41760625 | Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomas. | Nat Commun | 2026 | https://conductscience.org/library/papers/41760625 | PubMed |
| 41132165 | Extranodal NK/T-cell lymphoma: an update of the molecular characterization of the tumor and microenvironment, and its clinical implications. | Lancet Reg Health West Pac | 2025 | https://conductscience.org/library/papers/41132165 | PubMed |
| 40699642 | Genetic and Epigenetic Aberrations of SOX7 in Newly Diagnosed and Relapsed Multiple Myeloma as Well as Related Neoplasms. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699642 | PubMed |
| 39575767 | Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/39575767 | PubMed |
| 39460806 | The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. | Inflammation | 2025 | https://conductscience.org/library/papers/39460806 | PubMed |
| 39213420 | New insights into the biology of T-cell lymphomas. | Blood | 2024 | https://conductscience.org/library/papers/39213420 | PubMed |
| 39175124 | Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma. | Chin Med J (Engl) | 2024 | https://conductscience.org/library/papers/39175124 | PubMed |
| 38819423 | Aberrant methylation and expression of TNXB promote chondrocyte apoptosis and extracullar matrix degradation in hemophilic arthropathy via AKT signaling. | Elife | 2024 | https://conductscience.org/library/papers/38819423 | PubMed |
| 38546691 | MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications. | Haematologica | 2024 | https://conductscience.org/library/papers/38546691 | PubMed |
| 38544480 | Wemics: A Single-Base Resolution Methylation Quantification Method for Enhanced Prediction of Epigenetic Regulation. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38544480 | PubMed |
| 38203502 | Consideration of SHP-1 as a Molecular Target for Tumor Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203502 | PubMed |
| 38178117 | Therapeutic challenges in peripheral T-cell lymphoma. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38178117 | PubMed |
| 38037802 | Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders. | Haematologica | 2023 | https://conductscience.org/library/papers/38037802 | PubMed |
| 37781191 | Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms. | Front Oncol | 2023 | https://conductscience.org/library/papers/37781191 | PubMed |
| 37480137 | Novel target and treatment agents for natural killer/T-cell lymphoma. | J Hematol Oncol | 2023 | https://conductscience.org/library/papers/37480137 | PubMed |
| 37032358 | Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37032358 | PubMed |
| 36900160 | Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36900160 | PubMed |
| 36637656 | Mature T-cell and NK-cell lymphomas: updates on molecular genetic features. | Int J Hematol | 2023 | https://conductscience.org/library/papers/36637656 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25614448
GET https://conductscience.org/api/papers/v1/25614448/references?page=2